RenovoRx Statistics
Share Statistics
RenovoRx has 24.00M shares outstanding. The number of shares has increased by 124.45% in one year.
| Shares Outstanding | 24.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.06% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 23.54M |
| Failed to Deliver (FTD) Shares | 5.24K |
| FTD / Avg. Volume | 7.87% |
Short Selling Information
The latest short interest is 71.85K, so 0.3% of the outstanding shares have been sold short.
| Short Interest | 71.85K |
| Short % of Shares Out | 0.3% |
| Short % of Float | 0.31% |
| Short Ratio (days to cover) | 3.43 |
Valuation Ratios
The PE ratio is -2.3 and the forward PE ratio is -2.8.
| PE Ratio | -2.3 |
| Forward PE | -2.8 |
| PS Ratio | 0 |
| Forward PS | 2.3 |
| PB Ratio | -7.86 |
| P/FCF Ratio | -2.3 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for RenovoRx Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.
| Current Ratio | 1.25 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -105.52 |
Financial Efficiency
Return on equity (ROE) is 3.41% and return on capital (ROIC) is 379.87%.
| Return on Equity (ROE) | 3.41% |
| Return on Assets (ROA) | -6.98% |
| Return on Capital (ROIC) | 379.87% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.28M |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 23.15% in the last 52 weeks. The beta is 0.99, so RenovoRx 's price volatility has been higher than the market average.
| Beta | 0.99 |
| 52-Week Price Change | 23.15% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 52.12 |
| Average Volume (20 Days) | 66.49K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -11.40M |
| Net Income | -10.23M |
| EBITDA | -11.39M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.99 |
Balance Sheet
The company has 1.17M in cash and 0 in debt, giving a net cash position of 1.17M.
| Cash & Cash Equivalents | 1.17M |
| Total Debt | 0 |
| Net Cash | 1.17M |
| Retained Earnings | -41.41M |
| Total Assets | 10.03M |
| Working Capital | 8.26M |
Cash Flow
In the last 12 months, operating cash flow was -10.26M and capital expenditures 0, giving a free cash flow of -10.26M.
| Operating Cash Flow | -10.26M |
| Capital Expenditures | 0 |
| Free Cash Flow | -10.26M |
| FCF Per Share | -1 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RNXT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -74.44% |
| FCF Yield | -32.13% |
Analyst Forecast
The average price target for RNXT is $6.5, which is 388.7% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.5 |
| Price Target Difference | 388.7% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -2.17 |
| Piotroski F-Score | 2 |